Vestal Point Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.77M	Buy	+30,000	New	+$3.77M	0.2%	58
2024 Q2	–	Sell	-710,000	Closed	-$97.9M	–	73
2024 Q1	$97.9M	Sell	710,000 -90,000	-11%	-$12.4M	8.1%	3
2023 Q4	$105M	Buy	+800,000	New	+$105M	11.17%	1